Navigation Links
Two Of The Nation's Top Specialists In Lupus, Drs. Swamy Venuturupalli & Daniel Wallace, Join In Expanding Research On Auto-Immune Diseases
Date:4/1/2013

y and alternative medicine, publishing studies on Ayurvedic medicine, dietary supplements, and mind-body medicine. He participates in ongoing rheumatology research at the Cedars Sinai Division of Rheumatology and has authored numerous text-book chapters.

For the past ten years, Dr. Venuturupalli has held a private practice in association with a group of rheumatologists.  Dr. Venuturupalli is married with 2 children. His wife; also a physician, is Medical Director for Womens' health in Los Angeles county.


'/>"/>
SOURCE Dr. Swamy Venuturupalli
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Next-Generation Drug-Device Combinations Provide Innovative Delivery Methods for the Growing Biologics Market
2. SynCardias 50cc Total Artificial Heart Receives Two HUD Designations from the FDA for Destination Therapy and Pediatric Bridge to Transplant
3. Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
4. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
5. Nearly Half of Children Under 2 Years of Age Receive Some Vaccinations Late
6. BI-LO Offers Health Giveaways With Flu Vaccinations, Encourages Community To Shield Their Health This Flu Season
7. NationsHealth, Inc. Boosts Arizona Economy With Business Expansion
8. MLB All-Star Pitcher CC Sabathia Issues Fast Relief Challenge to Generate Donations for the American Red Cross
9. Nominations Open for San Francisco Business Times Health Care Heroes Awards
10. Central Nervous System Drug Delivery Specialists
11. Imaging Healthcare Specialists Among the First in the Nation to Offer Imaging Diagnosis for Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... -- Compass Diversified Holdings (NYSE: CODI ) ("CODI," ... middle market businesses, announced today its consolidated operating results ... 2014. Fourth Quarter 2014 Highlights , ... or "Cash Flow") of $17.5 million for the fourth ... year 2014;  , Reported net income of $8.9 ...
(Date:3/2/2015)... , March 2, 2015  DURECT Corporation ... Epigenomic Regulator Program, and the successful completion of ... lead product candidate DUR-928.  DUR-928 is an endogenous, ... broad applicability in metabolic diseases such as nonalcoholic ... and in acute organ injuries such as acute ...
(Date:3/2/2015)... 2015 Click here for additional information on ... DPLO ), the nation,s largest independent specialty pharmacy, ... 31, 2014. All comparisons, unless otherwise noted, are to the ... Fourth Quarter 2014 Highlights include: , Revenue of ... dispensed of 208,000, an increase of 11% , Gross ...
Breaking Medicine Technology:Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 2Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 4Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 5Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 6Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 7Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 8Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 9Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 10Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 12Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 13Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 14Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 15DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 2Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 3Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 4Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 6Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 7Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 8Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 9Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 10Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 11Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 13Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 14Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 15Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 16Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 17Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 18
... Inc. (OTCQX: DATA), a technology and services company ... trials industry, today announced its participation in the ... will address significant milestones made throughout the pharmaceutical ... technologies are delivering. The EuroMeeting will be held ...
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) ... launch of its new formulation of Acetadote ® ... treat acetaminophen poisoning. The proprietary new formulation, which does ... other stabilization or chelating agents, is now stocked at ...
Cached Medicine Technology:DATATRAK to Attend DIA's 23rd Annual EuroMeeting 2New Acetadote® Formulation Now Available in the U.S. 2New Acetadote® Formulation Now Available in the U.S. 3New Acetadote® Formulation Now Available in the U.S. 4
(Date:3/2/2015)... New York (PRWEB) March 02, 2015 ... of women who were allegedly harmed by the long-acting ... and federal courts around the U.S., according to Bernstein ... District Court, Eastern District of California on February 24th, ... case pending in that jurisdiction may pursue her lawsuit, ...
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative naturopathic ... to bring about self-renewal. A 30 day detox is ... cleaning house. According to Dr. Cutler, expert in ... environmental toxins like heavy metals, people’s food now becoming ... levels, we all have a level of toxic burden. ...
(Date:3/2/2015)... Monroeville, PA (PRWEB) March 02, 2015 ... part of the Allegheny Health Network, are ... with new software called Visual Info Zonal Reminder (VIZR), ... , Introduced in 2013, Google Glass is a wearable ... in a smartphone-like hands-free format. Wearers communicate with the ...
(Date:3/2/2015)... 02, 2015 GBCHealth, a prominent ... private sector activities and investments in global health ... four new members to serve on the organization’s ... Farmer, Chief Strategist and Co-founder of Partners In ... Dr. Huma Abbasi, General Manager of Global Health ...
(Date:3/2/2015)... UK (PRWEB) March 02, 2015 Market ... research reports worked out by Global Industry Analysts Inc ... Therapy Equipment: Market Research Report . Through 2018, the ... a 6.04% CAGR. The detailed research report suggests a ... for radiation therapy equipment as well as covers the ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Court’s Decision to Allow Certain Claims to Stand in Mirena Injury Case 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Court’s Decision to Allow Certain Claims to Stand in Mirena Injury Case 3Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Court’s Decision to Allow Certain Claims to Stand in Mirena Injury Case 4Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3
... of this year, colonoscopy screening will have prevented bowel ... introduced in Germany. This is the result obtained by ... Heidelberg and his co-authors in their interim assessment conducted ... German cancer screening program. The authors present their projection ...
... Many aspects of the German Genetic Diagnostics Act (Gendiagnostikgesetz) ... impossible to implement in clinical practice, or even detrimental ... newborn screening. The Act, which came into force in ... was the conclusion reached by the Academy Workgroup "Predictive ...
... WEDNESDAY, Nov. 10 (HealthDay News) -- U.S. college students ... move through their academic career, a new study has ... less active and heavier compared to the start of ... study author Jeanne Johnston, assistant professor in Indiana University,s ...
... HealthDay Reporter , WEDNESDAY, Nov. 10 (HealthDay News) -- ... increase the risk of cancer and may even decrease users, ... finds. Studies have shown that the short-term use of ... has little effect on the risk of developing cancer, but ...
... -- Women who were victims of childhood abuse may be ... suggest. Researchers surveyed 67,853 U.S. nurses and found that ... abuse before age 18. Moderate and severe physical and sexual ... increased risk of type 2 diabetes in adulthood. "Much, ...
... Nicolas Bazan, Boyd Professor, Villere Chair, and Director of the ... shown that Docosahexaenoic acid (DHA), a component of fish ... tissue and promote recovery in an experimental model of acute ... five hours. These findings not only target a new stroke ...
Cached Medicine News:Health News:Academies of science call for amendments to impracticable Genetic Diagnostics Act 2Health News:Academies of science call for amendments to impracticable Genetic Diagnostics Act 3Health News:Activity Level Seems to Decline Throughout College Years 2Health News:Long-Term Statin Use Won't Raise Cancer Risk: Study 2Health News:Childhood Abuse Linked to Diabetes Risk in Adult Women 2Health News:Louisiana State University Health Sciences Center research shows fish oil component given up to 5 hours after stroke limits brain damage 2Health News:Louisiana State University Health Sciences Center research shows fish oil component given up to 5 hours after stroke limits brain damage 3
... X-22 Series is up to 10 inches/ 25 cm ... 11 rotors, the Allegra X-22 Series is the space-saving ... Only 18 inches / 46 cm wide • 11 ... 3 different ways to Spin 1.5 mL & ...
... purpose centrifuges offer high-volume versatility along with ... making them ideal for a wide variety ... Four- or six-place sealed swinging bucket ... rotors offered , Lare capacity (4 x ...
... high performance centrifuge designed to accommodate over ... is refrigerated for heat labile samples. Incorporating ... refrigerated capability with automatic quick cooling from ... 7 min, no maintenance brushless motor, low ...
Inquire...
Medicine Products: